CID 16204659

5'-gtgagggcg-3'

Structural Information

Molecular Formula
C89H111N40O46P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)O)N4C=NC5=C4N=C(NC5=O)N)OP(=S)(O)OCC6C(CC(O6)N7C=NC8=C7N=C(NC8=O)N)OP(=S)(O)OCC9C(CC(O9)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O)S
InChI
InChI=1S/C89H111N40O46P9S9/c1-31-13-122(89(139)120-75(31)131)53-6-34(44(161-53)17-153-179(144,188)170-35-8-55(162-42(35)15-150-176(140,141)185)125-26-102-62-70(125)109-83(93)115-77(62)133)169-178(143,187)155-19-46-38(10-57(164-46)127-28-104-64-72(127)111-85(95)117-79(64)135)173-182(147,191)154-18-45-36(7-54(163-45)123-24-100-60-67(91)98-23-99-68(60)123)171-181(146,190)156-20-47-39(11-58(165-47)128-29-105-65-73(128)112-86(96)118-80(65)136)174-184(149,193)158-22-49-40(12-59(167-49)129-30-106-66-74(129)113-87(97)119-81(66)137)175-183(148,192)157-21-48-37(9-56(166-48)126-27-103-63-71(126)110-84(94)116-78(63)134)172-180(145,189)152-16-43-33(5-52(160-43)121-3-2-50(90)107-88(121)138)168-177(142,186)151-14-41-32(130)4-51(159-41)124-25-101-61-69(124)108-82(92)114-76(61)132/h2-3,13,23-30,32-49,51-59,130H,4-12,14-22H2,1H3,(H,142,186)(H,143,187)(H,144,188)(H,145,189)(H,146,190)(H,147,191)(H,148,192)(H,149,193)(H2,90,107,138)(H2,91,98,99)(H,120,131,139)(H2,140,141,185)(H3,92,108,114,132)(H3,93,109,115,133)(H3,94,110,116,134)(H3,95,111,117,135)(H3,96,112,118,136)(H3,97,113,119,137)
InChIKey
WMAKIZGJPHYFDW-UHFFFAOYSA-N
Compound name
1-[4-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-sulfanylphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(dihydroxyphosphinothioyloxymethyl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

3042.27 Da
Monoisotopic Mass

-6.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3043.2773 295.2
[M+Na]+ 3065.2592 298.5
[M-H]- 3041.2627 295.4
[M+NH4]+ 3060.3038 296.4
[M+K]+ 3081.2332 296.9
[M+H-H2O]+ 3025.2673 295.6
[M+HCOO]- 3087.2682 296.6
[M+CH3COO]- 3101.2839 297.0
[M+Na-2H]- 3063.2447 299.2
[M]+ 3042.2695 298.6
[M]- 3042.2705 298.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.